Lipid effects of psychiatric medications

Junzo Watanabe1, Yutaro Suzuki, Toshiyuki Someya

  • 1Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, 757 Asahimachidori-ichibancho, Chuo-ku, Niigata, 951-8510, Japan. junzo-w@umin.net

Insights

Patients with schizophrenia face higher risks of cardiovascular disease, often linked to dyslipidemia from antipsychotic medications. Regular fasting lipid measurements are crucial for managing these risks in schizophrenia patients.

Area of Science:

  • Psychiatry
  • Cardiology
  • Pharmacology

Background:

  • Schizophrenia patients experience elevated medical illness and mortality rates.
  • Cardiovascular disease is a primary cause of premature death in schizophrenia.
  • Dyslipidemia is a significant risk factor for cardiovascular disease, prevalent in schizophrenia.

Purpose of the Study:

  • To highlight the link between second-generation antipsychotic agents and dyslipidemia.
  • To discuss the association of depression with cardiovascular risks.
  • To recommend strategies for reducing cardiovascular disease risk in schizophrenia patients.

Main Methods:

  • Literature review on dyslipidemia and cardiovascular disease in schizophrenia.
  • Analysis of the impact of antipsychotic agents on lipid profiles.
  • Examination of depression's role in cardiovascular health.

Main Results:

  • Second-generation antipsychotics are associated with a high prevalence of dyslipidemia.
  • Depression correlates with increased risks of diabetes, hypertension, and cardiovascular disease.
  • Antidepressant effects on lipid profiles require further investigation.

Conclusions:

  • Fasting lipid measurements are essential for monitoring schizophrenia patients on antipsychotics.
  • Proactive cardiovascular risk management is needed for this population.
  • Further research is warranted on antidepressant effects on lipid profiles.

Related Concept Videos

Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
665
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
943
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
315
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
964
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
550
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.5K